MarketResearchReports.Biz adds “Global TransMedics Inc Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the TransMedics Inc market and the growth estimates for the forecasted period.
TransMedics Inc (TransMedics) is a medical device company that develops organ transplant systems. The company offers organ care systems that are used by surgeons in heart transplants and ex-vivo warm perfusion and assessment of donor organs for transplantation. Its organ care systems are also used for lung, liver and kidney transplants. TransMedics product functions include blood oxygenation, pulsative flow, physiological monitoring and warming. The company enables surgeons to transplant more organs from the available donor pool. Its products are clinical use in transplant centers in Europe, Australia and Canada, and undergoing clinical trials in the US. TransMedics is headquartered in Andover, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1833111
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company TransMedics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Request For TOC Report @https://www.marketresearchreports.biz/reports/1833111/transmedics-inc-product-pipeline-analysis-2018-update-market-research-reports/toc
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
TransMedics Inc Company Overview 4
TransMedics Inc Company Snapshot 4
TransMedics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
TransMedics Inc Pipeline Analysis Overview 7
TransMedics Inc - Key Facts 7
TransMedics Inc - Major Products and Services 8
TransMedics Inc Pipeline Products by Development Stage 9
TransMedics Inc Ongoing Clinical Trials by Trial Status 11
TransMedics Inc Pipeline Products Overview 13
OCS Heart Device 13
OCS Heart Device Product Overview 13
OCS Heart Device Clinical Trial 14
OCS Kidney Device 15
OCS Kidney Device Product Overview 15
OCS Liver Device 16
OCS Liver Device Product Overview 16
OCS Liver Device Clinical Trial 17
TransMedics Inc - Key Competitors 18
TransMedics Inc - Key Employees 19
TransMedics Inc - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
TransMedics Inc, Recent Developments 21
Apr 12, 2018: TransMedics Receives FDA Pre-Market Approval (PMA) for its OCS Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation 21
Apr 12, 2018: The Results of the OCS Lung INSPIRE Trial Published in The Lancet Respiratory Medicine Journal 21
Apr 04, 2018: Baylor St. Luke''''s Medical Center First in Texas to Perform Breathing Lung Transplant Using the Organ Care System Lung Technology 22
Dec 19, 2017: Ventripoint Provides Corporate Update 22
Mar 29, 2016: University of Michigan Health System tests beating heart transplants 23
Feb 23, 2016: TransMedics Announces The World's First Human Liver Transplantation Using The Organ Care System (OCS) Liver Technology & The Initiation of The OCS Liver PROTECT U.S. Pivotal Trial 24
Nov 02, 2015: FDA Postpones TransMedics Advisory Panel Meeting 24
Oct 01, 2015: FDA Panel To Discuss On TransMedics PMA Application For OCS Heart Device 25
Apr 15, 2015: The Lancet Publishes The First Ever Successful Series of Clinical Heart Transplants From DCD Donors Using The TransMedics Organ Care System 25
Apr 15, 2015: The Results of The International PROCEED II Heart Trial with the Organ Care System Were Published in The Prestigious Lancet Journal 26
Appendix 27
Methodology 27
About GlobalData 29
Contact Us 29
Disclaimer 30
TransMedics Inc (TransMedics) is a medical device company that develops organ transplant systems. The company offers organ care systems that are used by surgeons in heart transplants and ex-vivo warm perfusion and assessment of donor organs for transplantation. Its organ care systems are also used for lung, liver and kidney transplants. TransMedics product functions include blood oxygenation, pulsative flow, physiological monitoring and warming. The company enables surgeons to transplant more organs from the available donor pool. Its products are clinical use in transplant centers in Europe, Australia and Canada, and undergoing clinical trials in the US. TransMedics is headquartered in Andover, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1833111
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company TransMedics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Request For TOC Report @https://www.marketresearchreports.biz/reports/1833111/transmedics-inc-product-pipeline-analysis-2018-update-market-research-reports/toc
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
TransMedics Inc Company Overview 4
TransMedics Inc Company Snapshot 4
TransMedics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
TransMedics Inc Pipeline Analysis Overview 7
TransMedics Inc - Key Facts 7
TransMedics Inc - Major Products and Services 8
TransMedics Inc Pipeline Products by Development Stage 9
TransMedics Inc Ongoing Clinical Trials by Trial Status 11
TransMedics Inc Pipeline Products Overview 13
OCS Heart Device 13
OCS Heart Device Product Overview 13
OCS Heart Device Clinical Trial 14
OCS Kidney Device 15
OCS Kidney Device Product Overview 15
OCS Liver Device 16
OCS Liver Device Product Overview 16
OCS Liver Device Clinical Trial 17
TransMedics Inc - Key Competitors 18
TransMedics Inc - Key Employees 19
TransMedics Inc - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
TransMedics Inc, Recent Developments 21
Apr 12, 2018: TransMedics Receives FDA Pre-Market Approval (PMA) for its OCS Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation 21
Apr 12, 2018: The Results of the OCS Lung INSPIRE Trial Published in The Lancet Respiratory Medicine Journal 21
Apr 04, 2018: Baylor St. Luke''''s Medical Center First in Texas to Perform Breathing Lung Transplant Using the Organ Care System Lung Technology 22
Dec 19, 2017: Ventripoint Provides Corporate Update 22
Mar 29, 2016: University of Michigan Health System tests beating heart transplants 23
Feb 23, 2016: TransMedics Announces The World's First Human Liver Transplantation Using The Organ Care System (OCS) Liver Technology & The Initiation of The OCS Liver PROTECT U.S. Pivotal Trial 24
Nov 02, 2015: FDA Postpones TransMedics Advisory Panel Meeting 24
Oct 01, 2015: FDA Panel To Discuss On TransMedics PMA Application For OCS Heart Device 25
Apr 15, 2015: The Lancet Publishes The First Ever Successful Series of Clinical Heart Transplants From DCD Donors Using The TransMedics Organ Care System 25
Apr 15, 2015: The Results of The International PROCEED II Heart Trial with the Organ Care System Were Published in The Prestigious Lancet Journal 26
Appendix 27
Methodology 27
About GlobalData 29
Contact Us 29
Disclaimer 30
No comments:
Post a Comment